Rochester Regional Health Joins the Cardiometabolic Center Alliance as a Charter Member
Kansas City, Missouri and Rochester, New York–The Cardiometabolic Center Alliance (CMCA), founded by Saint Luke’s Mid America Heart Institute is honored to announce the addition of Rochester Regional Health as Charter Member.
As a coalition that seeks to establish Cardiometabolic Centers of Excellence nationwide aimed at transforming the treatment of type 2 diabetes (T2D), and related cardiovascular (CV) and renal comorbidities, the CMCA considers Rochester Regional Health—a leading integrated health services organization, consisting of five hospitals, more than 2,500 medical staff, 936 long-term care beds, eight senior living facilities, nearly 90 primary care and ambulatory locations, 54 patient lab testing sites, and extensive home health programs in the Western New York and the Finger Lakes area a key member of the alliance.
“Cardiometabolic disease is one of the leading population health threats impacting our communities and patients regardless of where they may live. The Cardiometabolic Center Alliance is proud to partner with Rochester Regional Health as the newest member of the CMCA as their commitment to providing the highest quality cardiometabolic care to the communities they serve compliments with the overarching mission of the CMCA”, said Mikhail Kosiborod MD, Cardiometabolic Center Alliance Executive Director.
“We are absolutely thrilled to be Charter Members of the Cardiometabolic Center Alliance. Dr. Kosiborod and his team are world-renowned leaders for their management of complex patients with cardiac disease and underlying co-morbidities such as diabetes, obesity and kidney disease. Rochester Regional Health is excited to have the opportunity to partner with a nationally recognized team and provide cutting edge and state-of-the-art care right here in Rochester, NY! Our mission, which very much overlaps with the CMCA, is to provide a comprehensive medical home for these patients, using a multi-disciplinary team model including cardiologists, endocrinologists, bariatric specialists, dieticians and many others to ensure patients are afforded every opportunity to live a full and meaningful life, despite the burden of diabetes and heart disease. As a charter member of this alliance we will also gain access to cutting edge clinical trials that may further improve outcomes for these patients! This is a huge win for patients in upstate New York!” –Scott Feitell, Director of Heart Failure, charter member of Cardiometabolic Center Alliance
Alliance members will adopt and implement a novel care model designed and successfully implemented by Saint Luke’s Michael & Marlys Haverty Cardiometabolic Center of Excellence in Kansas City, MO. Based on the initial data, under this model the rates of optimal guideline-directed medical therapy substantially increased over the national average, ensuring that patients with T2D receive care that is aimed at both optimizing diabetes management and providing comprehensive cardiovascular risk reduction with therapies proven to improve outcomes. These results are made possible by a unified team of clinicians from across the disease continuum, who focus on holistic, guideline-directed preventative care. Through their participation, Alliance members will also contribute to a national registry that will track treatment patterns and quality of care. As the Alliance enhances its capabilities, improves processes, and expands research opportunities on a national scale, the ultimate goal is improved patient outcomes.